Charles Russell Speechlys advises Apposite Capital on their investment into Mirada Medical
Charles Russell Speechlys has advised healthcare investor Apposite Capital on its £6m investment into medical imaging software business Mirada Medical Limited. Mirada is a leading developer of artificial intelligence (AI) based software which increases the speed and accuracy of cancer treatment planning applications, while delivering a more personalised level of care to patients. Apposite has invested alongside Mirada’s founding investor, Albion Capital, and other private investors.
Sam Gray, Partner at Apposite Capital, commented “We were delighted to work with Richard and team at Charles Russell Speechlys on this deal and appreciated their joined up approach and pragmatic and commercial outlook."
The Charles Russell Speechlys team comprised Rajiv Kakkad and Lydia Zakrzewski (Private Equity), Kirsti Laird (Employment), Caroline Young and Jaclyn Wilkins (Commercial and IP) and Helen Coward and Elliot Michaelson (Tax).
News & Insights
Charles Russell Speechlys releases H2 2020 deal highlights
Our highlights over the past 6 months are now available.
FCA publishes listing rule on enhanced climate-related disclosures and clarifies existing obligations
Premium listed commercial companies should start addressing what they need to do to make the required disclosures in sufficient detail.